Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

324
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and late mortality among patients with T1-T3 head and neck squamous cell carcinoma: a machine learning analysis using a SEER population-based cohort study.

Scientific reports·2026
Same author

Reply to Borewad et al. Comment on "Rao et al. The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis. <i>Cancers</i> 2025, <i>17</i>, 862".

Cancers·2026
Same author

Gingipain-Mediated Matrix Metalloproteinase-8 and -9 Activation in Oral Rinse Samples from Patients with Cancer: A Cross-Sectional Study.

Dentistry journal·2026
Same author

The Prognostic Significance of Tertiary Lymphoid Structures in Head and Neck Cancers: A Systematic Review and Meta-Analysis.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2026
Same author

Treatment-Related Adverse Event Claims in Otorhinolaryngology-Head and Neck Surgery: A Nationwide Finnish Review (2012-2023).

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2026
Same author

Absence of DNA viruses in ameloblastomas.

European journal of oral sciences·2026

Related Experiment Video

Updated: May 31, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K

Predicting Early Death in Head and Neck Cancer-A Pilot Study.

Charbél Talani1,2, Hans Olsson3, Karin Roberg2,4

  • 1Division of Sensory Organs and Communication, Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden.

Cancers
|January 25, 2025
PubMed
Summary
This summary is machine-generated.

Head and neck cancer (HNC) patients with high Ki67 and survivin expression in tumor biopsies face a greater risk of early death. These biomarkers may aid in predicting prognosis and guiding treatment decisions.

Keywords:
biomarkersearly deathearly mortalityhead and neck cancerhead and neck squamous cell carcinomasurvivin

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

205
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: May 31, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

205
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Oncology
  • Biomarker Research
  • Cancer Diagnostics

Background:

  • Head and neck cancer (HNC) poses a significant mortality risk.
  • Accurate prognostication is crucial for effective HNC management.
  • Identifying reliable biomarkers for early death risk in HNC is an unmet clinical need.

Purpose of the Study:

  • To evaluate tumor biopsy biomarkers and biological characteristics in HNC patients.
  • To assess the risk of early mortality within six months of diagnosis.
  • To determine if marker combinations can prognosticate early death in HNC.

Main Methods:

  • Retrospective analysis of HNC patients.
  • Inclusion of patients who died within six months of diagnosis and matched survivors (at least two years).
  • Comparison of marker expression (Ki-67, survivin) between early-death and survivor groups.

Main Results:

  • Significantly higher Ki-67 expression in early-death patients (mean difference 21%, p=0.038).
  • Increased cytoplasmic survivin expression in early-death patients (p=0.021).
  • Significant difference in survivin staining intensity between groups (p=0.006).

Conclusions:

  • Ki67 and survivin show potential as prognostic biomarkers for early death in HNC.
  • These markers may be valuable additions to prognostic panels for HNC treatment decisions.
  • This pilot study highlights the need for further validation of these biomarkers.